Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P010013/S094

NovaSure Model 10 RF Controller

Hologic, Inc. · Decision date Dec 17, 2025

FDA DECISIONP010013/S094

What did the FDA decide?

FDA records P010013/S094 as a supplement to PMA P010013, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Dec 17, 2025.

FDA approval order statement

a new supplier of the LCD screen
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Obstetrics/Gynecology
Decision date
Dec 17, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P010013/S094
Regulatory pathway
PMA supplement
Applicant
Hologic, Inc.
Product code
MNB
Decision code
OK30
Decision date
Dec 17, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Device, thermal ablation, endometrial.

Applicant
Hologic, Inc.
Product code
MNB
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P010013/S094 received

    Application receipt date recorded by FDA.

  2. P010013/S094 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P010013. View FDA’s full supplement list.

Related devices and submissions

Explore the linked device profile

Other records with product code MNB

Product / regulatory recordCompanyPathwayDecision dateSource
Axora Medical, Inc.PMA supplementNov 5, 2026FDA
Channel Medsystems, Inc.PMA supplementNov 3, 2026FDA
Channel Medsystems, Inc.PMA supplementSep 15, 2026FDA
MICROCUBE, LLCPMA supplementJul 13, 2026FDA
Channel Medsystems, Inc.PMA supplementJul 8, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Hologic, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
250 Campus Dr., Malborough, MA, 01752

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records